The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 1) Holly Fernandez Lynch Reshma Ramachandran Rachel Sachs Steven Joffe Patricia J. Zettler January 22, 2026

https://www.healthaffairs.org/content/forefront/promise-and-perils-fda-s-new-plausible-mechanism-pathway-part-1